[Measuring the HIV viral load with LCx (Abbott): importance for the therapeutic follow-up of 3 patients infected by type O HIV]

Transfus Clin Biol. 2003 Apr;10(2):72-3. doi: 10.1016/s1246-7820(03)00025-9.
[Article in French]
No abstract available

Publication types

  • Evaluation Study

MeSH terms

  • Alkynes
  • Anti-HIV Agents / pharmacology
  • Anti-HIV Agents / therapeutic use
  • Antiretroviral Therapy, Highly Active
  • Benzoxazines
  • Cyclopropanes
  • Drug Resistance, Multiple, Viral
  • Female
  • Follow-Up Studies
  • HIV Infections / blood
  • HIV Infections / drug therapy
  • HIV Infections / virology*
  • HIV Protease Inhibitors / pharmacology
  • HIV Protease Inhibitors / therapeutic use
  • HIV-1 / classification
  • HIV-1 / drug effects
  • HIV-1 / isolation & purification*
  • Humans
  • Indinavir / pharmacology
  • Indinavir / therapeutic use
  • Lamivudine / pharmacology
  • Lamivudine / therapeutic use
  • Male
  • Oxazines / pharmacology
  • Oxazines / therapeutic use
  • Polymerase Chain Reaction / instrumentation
  • Polymerase Chain Reaction / methods*
  • Reverse Transcriptase Inhibitors / pharmacology
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Ritonavir / pharmacology
  • Ritonavir / therapeutic use
  • Stavudine / pharmacology
  • Stavudine / therapeutic use
  • Viral Load*
  • Viremia / virology*
  • Zidovudine / pharmacology
  • Zidovudine / therapeutic use

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • HIV Protease Inhibitors
  • Oxazines
  • Reverse Transcriptase Inhibitors
  • Lamivudine
  • Zidovudine
  • Indinavir
  • Stavudine
  • efavirenz
  • Ritonavir